X0306 4 2021-07-26 0 0001672688 Absci Corp ABSI 0001647900 Phoenix Venture Partners II LP 1700 EL CAMINO REAL, SUITE 355 SAN MATEO CA 94402 0 0 1 0 0001874106 Phoenix General Partner II LLC 1700 EL CAMINO REAL, SUITE 355 SAN MATEO CA 94402 0 0 1 0 Common Stock 2021-07-26 4 C 0 5681332 A 5681332 D Common Stock 2021-07-26 4 C 0 533735 A 6215067 D Common Stock 2021-07-26 4 C 0 4954650 A 11169717 D Common Stock 2021-07-26 4 C 0 2590991 A 13760708 D Common Stock 2021-07-26 4 C 0 273130 A 14033838 D Common Stock 2021-07-26 4 C 0 84348 A 14118186 D Common Stock 2021-07-26 4 C 0 33741 A 14151927 D Common Stock 2021-07-26 4 C 0 33675 A 14185602 D Series A-1 Preferred Stock 2021-07-26 4 C 0 1720000 0.00 D Common Stock 5681332 0 D Series A-2 Preferred Stock 2021-07-26 4 C 0 161586 0.00 D Common Stock 533735 0 D Series A-3 Preferred Stock 2021-07-26 4 C 0 1500000 0.00 D Common Stock 4954650 0 D Series B Preferred Stock 2021-07-26 4 C 0 784412 0.00 D Common Stock 2590991 0 D Series C Preferred Stock 2021-07-26 4 C 0 82689 0.00 D Common Stock 273130 0 D Series D-1 Preferred Stock 2021-07-26 4 C 0 25536 0.00 D Common Stock 84348 0 D Series D-2 Preferred Stock 2021-07-26 4 C 0 10215 0.00 D Common Stock 33741 0 D Series E Preferred Stock 2021-07-26 4 C 0 10195 0.00 D Common Stock 33675 0 D Series A-4 Preferred Stock Warrant 1.00 2021-07-26 4 C 0 93007 0.00 D 2026-09-29 Series A-4 Preferred Stock 93007 0 D Common Stock Warrant 1.00 2021-07-26 4 C 0 307211 0.00 A 2026-09-29 Common Stock 307211 0 D The Series A-1 Preferred Stock converted into Common Stock on a one-for-3.3031 basis and had no expiration date. Reflects one-for-3.3031 stock split which became effective on July 26, 2021. Phoenix General Partner II LLC, as the sole general partner of Phoenix Venture Partners II LP, beneficially owns the reported securities indirectly, but disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. The Series A-2 Preferred Stock converted into Common Stock on a one-for-3.3031 basis and had no expiration date. The Series A-3 Preferred Stock converted into Common Stock on a one-for-3.3031 basis and had no expiration date. The Series B Preferred Stock converted into Common Stock on a one-for-3.3031 basis and had no expiration date. The Series C Preferred Stock converted into Common Stock on a one-for-3.3031 basis and had no expiration date. The Series D-1 Preferred Stock converted into Common Stock on a one-for-3.3031 basis and had no expiration date. The Series D-2 Preferred Stock converted into Common Stock on a one-for-3.3031 basis and had no expiration date. The Series E Preferred Stock converted into Common Stock on a one-for-3.3031 basis and had no expiration date. Prior to July 26, 2021, these warrants were exercisable by the holder at its option for shares of the Issuer's Series A-4 Preferred Stock at an exercise price of $1.00 per share any time prior to their expiration date. The warrant for 93,007 shares of Series A-4 Preferred Stock converted into a warrant for 307,211 shares of Common Stock upon the one-for-3.3031 reverse split. /s/ Zachariah Jonasson, Managing Member of sole general partner on behalf of Phoenix Venture Partners II LP 2021-07-28 /s/ Zachariah Jonasson, Managing Member on behalf of Phoenix General Partner II LLC 2021-07-28